Century Therapeutics (IPSC) Treasury Shares (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Treasury Shares data on file, last reported at $7.2 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 53.77% year-over-year to $7.2 million in Q1 2026; TTM through Mar 2026 was $7.2 million, a 53.77% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, up 97.9% from the prior year.
• Treasury Shares for Q1 2026 stood at $7.2 million, up from $5.6 million in the prior quarter.
• Over the last five years, Treasury Shares for IPSC reached as high as $58.5 million in Q4 2022 and fell as low as $24821.0 in Q4 2024.
• Historically, Treasury Shares has averaged $5.9 million across 5 years, with a median of $3.9 million in 2024.
• Across the five-year window, Treasury Shares tumbled 99.92% in 2023 and soared 22646.69% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $58.5 million in 2022, then tumbled by 99.92% to $49416.0 in 2023, then tumbled by 49.77% to $24821.0 in 2024, then surged by 22646.69% to $5.6 million in 2025, then increased by 27.37% to $7.2 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $7.2 million in Q1 2026, $5.6 million in Q4 2025, and $6.6 million in Q3 2025.